$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Long-term follow-up confirms the sustained efficacy of ivonib/tosuvo in IDH1-mutated AML
2026-02-01 22:25:32
Check Details
What is the selling price of Mitotane in China?
2026-02-01 22:25:32
Check Details
Bevacizumab combined with erlotinib in the treatment of hereditary and sporadic papillary renal cell carcinoma
2026-02-01 22:25:32
Check Details
Is tofacitinib used for pain relief when I have rheumatoid arthritis?
2026-02-01 22:25:32
Check Details
What is the relationship between cycloserine and dastrazeneca
2026-02-01 22:25:32
Check Details
Does Linezolid/Siwo have anti-tumor effects?
2026-02-01 22:25:32
Check Details
Is Avonib/Tosuvo effective in curing myeloid leukemia?
2026-02-01 22:25:32
Check Details
Is Mitotane a chemotherapy drug or a targeted drug?
2026-02-01 22:25:32
Check Details
Erlotinib manufacturer and R&D background
2026-02-01 22:25:32
Check Details
Will the price of tofacitinib be reduced if covered by insurance?
2026-02-01 22:25:32
Check Details
What is the therapeutic mechanism of cycloserine?
2026-02-01 22:25:32
Check Details
Is Linezolid/Siwo an imported drug?
2026-02-01 22:25:32
Check Details
1
2
...
1934
1935
1936
1937
1938
1939
1940
...
10226
10227
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Elamipretide Side Effects and Medication Safety Guide: Injection Site Reactions and Storage Essentials
2
Dutasteride Soft Capsules: Comprehensive Side Effect Profile and Management Strategies
3
Oral Semaglutide Tablets: A Complete Guide to the GLP-1 Receptor Agonist for Type 2 Diabetes and Cardiovascular Protection
4
Sotorasib (Lumakras): A Comprehensive Guide to the First KRAS G12C-Targeted Inhibitor
5
Comprehensive Interpretation of Osimertinib: Efficacy, Side Effects and Medication Standards
6
Sotorasib: Can the First KRAS G12C-Targeted Therapy Cure Cancer?
7
Trametinib (Mekinist): Refrigerated Storage, Fasting Administration, and BRAF Mutation Indications Explained
8
Asciminib (SCEMBLIX): STAMP Inhibitor Dosing Guide and Nomenclature Clarification for CML
9
Belzutifan (Welireg): HIF-2α Inhibitor for VHL-Associated Tumors and Renal Cell Carcinoma — Dosing Phases, Survival Data, and Efficacy Insights
10
Cabergoline Medication Guide: Contraindications, Treatment Costs, and Safety Monitoring Essentials
11
Pemigatinib vs. Anlotinib: Key Differences Between FGFR-Targeted Therapy and Multi-Target Anti-Angiogenic Treatment
12
Enasidenib (IDHIFA): A Comprehensive Guide to Targeted Therapy for IDH2-Mutated Acute Myeloid Leukemia